计算机辅助三维可视化治疗局部晚期甲状腺癌
June 9th, 2023
在诊断和治疗局部晚期甲状腺癌时，计算机辅助三维重建的应用可以提供有关肿瘤范围和解剖特征的额外信息，从而协助风险评估和手术计划。
计算机辅助三维重建可以提供有关肿瘤范围和解剖特征的信息，从而辅助风险评估和手术计划。计算机辅助三维重建可为局部晚期甲状腺癌的诊断和治疗提供信息。首先，使用 256 层螺旋 CT 系统获得患者的平板和增强 CT 图像。
以DICOM格式从CT系统获取扫描数据。然后通过单击"打开"按钮将数据导入 3D 可视化软件。如果数据包含图像噪声，请先用鼠标右键单击数据，然后单击高斯平滑按钮，以处理数据以进行高斯平滑。
接下来，根据要重建的结构（例如血管或皮肤）在软件中选择选项卡 不同的模型。设置颜色、最大阈值和最小阈值。根据观察到的预览效果调整上限和下限阈值。
重复该过程以获取其他结构（如骨骼）的分割数据。点击计算按钮，完成初步的3D模型重建。然后使用平滑算法按钮优化分割数据，并确保重建的锯齿边缘与真实组织匹配。
然后使用一键导航按钮定位 2D 和 3D 图像，并确定分割效果是否准确。使用钢笔或画笔工具修复不正确的图层。对于术前评估，查看 3D 模型并评估肿瘤体积和位置。
利用放大、旋转、组织透明度和分离功能，使用各种结构的组合来评估肿瘤与邻近组织之间的关系。对于一名 50 岁的甲状腺癌患者，使用 CT 血管造影进行的初步评估表明肿瘤涉及大量血管。利用CT数据，手术团队完成了肿瘤的计算机辅助3D建模。
对3D模型的评估揭示了肿瘤与血管之间的关系，并确定了进一步的手术程序。检查三维图像是否与CT图像一致对于成功重建非常重要。
View the full transcript and gain access to thousands of scientific videos
概述
本文讨论了计算机辅助三维重建在诊断和治疗局部晚期甲状腺癌中的应用。该技术增强了对肿瘤范围和解剖特征的理解，有助于风险评估和手术计划。
关键研究组成部分
科学领域
- 肿瘤学
- 医学影像
- 计算机辅助诊断
背景
- 局部晚期甲状腺癌提出了显著的治疗挑战。
- 对肿瘤特征的准确评估对于有效管理至关重要。
- 三维重建技术可以改善肿瘤的可视化。
- 计算机辅助方法增强了诊断能力。
研究目的
- 评估3D重建在甲状腺癌诊断中的有效性。
- 通过改善的解剖学见解辅助手术计划。
- 提高晚期甲状腺癌患者的风险评估。
使用的方法
- 使用256层螺旋CT系统获得普通和增强CT图像。
- 以DICOM格式导出扫描数据以进行分析。
- 将数据导入3D可视化软件进行重建。
- 如有必要，应用高斯平滑以减少图像噪声。
主要结果
- 3D重建提供了对肿瘤解剖结构的详细见解。
- 增强的可视化促进了更好的手术计划。
- 该方法提高了患者的风险评估准确性。
- 计算机辅助技术展示了在肿瘤学中更广泛应用的潜力。
结论
- 计算机辅助3D重建是甲状腺癌管理的有价值工具。
- 该技术有助于诊断和治疗计划。
- 进一步的研究可以扩大其在其他癌症类型中的应用。
常见问题
Executive Industry Relevance
Computer-aided three-dimensional (3D) visualization enables precise anatomical mapping and risk assessment in the management of locally advanced thyroid cancer. This technology enhances preoperative planning by providing detailed spatial relationships between tumors and critical structures, supporting more confident surgical decision-making. Integrating 3D modeling into oncology workflows can improve predictive confidence and streamline portfolio triage for complex surgical cases.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables detailed anatomical visualization to clarify tumor boundaries and invasion pathways.
- Supports functional assessment of tumor-structure relationships for biological de-risking.
- Improves predictive confidence in surgical feasibility and risk stratification.
Screening & Assay Development
- Facilitates the creation of validated 3D models for preclinical simulation and planning.
- Standardizes anatomical data inputs for reproducible surgical risk assessments.
- Provides quantitative outputs such as tumor volume and proximity to vessels for downstream analysis.
Translational & Preclinical Research
- Aligns imaging-derived models with disease-relevant anatomical features for translational continuity.
- Enables risk-adjusted advancement decisions based on individualized anatomical insights.
- Supports mechanistic de-risking by visualizing tumor-tissue interactions in preclinical models.
Pipeline & Workflow Integration
3D visualization integrates into the oncology discovery-to-preclinical continuum by bridging diagnostic imaging and surgical planning with quantitative, reproducible models.
- Discovery Biology: Provides high-resolution anatomical data for hypothesis testing and pathway clarification.
- Screening: Delivers standardized, reproducible 3D models for comparative risk assessment.
- Analytics: Enables quantitative measurement of tumor volume, invasion, and anatomical relationships.
- Translational Research: Ensures continuity from imaging-based discovery to preclinical and surgical validation.
- Enterprise Reuse: Establishes a reusable digital workflow for anatomical modeling across oncology indications.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in surgical planning.
- Operational Value: Standardizes preoperative evaluation and enhances reproducibility of anatomical assessments.
- Strategic Value: Improves go/no-go decisions and reduces late-stage surgical risk through enhanced visualization.
- Portfolio Impact: Supports risk-adjusted prioritization of complex surgical cases in oncology pipelines.
Implementation Considerations
- Requires expertise in medical imaging and 3D modeling software operation.
- Needs access to high-resolution CT imaging and compatible visualization platforms.
- Demands cross-team standardization for data acquisition and model validation.
- Adaptation may be needed for different tumor types or anatomical regions.
- Accuracy depends on image quality and segmentation precision as supported by the source.
